Patients with squamous cell carcinoma of the oral cavity are afflicted with a malignancy that frequently presents with advanced disease, and whose management often has profound effects upon these individual's speech, swallowing, cosmetic appearance, as well as survival. Unfortunately, despite advances in contemporary surgery and radiation therapy over the past thirty years, survival among these patients has remained essentially unaltered. Additionally, chemotherapy has shown little promise in the management of these cancers. Therefore, developing novel mechanisms of cessating these oral cancers may provide for important insights into the management of these patients. Initial investigations of wild-type p53 adenovirus has shown promise as a molecular intervention due to its function as a tumor suppressor gene and proposed role in apoptosis. However, significant advances are required in understanding the optimization of transduction efficiency in molecular therapy as well s increasing our understanding of the interaction of molecular intervention strategies in order to produce the desired effect of tumor cell demise. The applicant has elected to employ the adenovirus vector as a mechanism for molecular intervention due to its characteristic transient expression, efficacy of expression and ability to expand to high titers. Additionally, lack of permanent integration is favorable from a biosafety standpoint as compared to retrovirus vectors. This proposal, therefore, submits to further develop our understanding of molecular therapy for oral cavity squamous carcinomas through the following specific aim: 1. To determine the maximal transfection efficiency of adenovirus vectors in the transient expression of marker genes in oral squamous carcinomas. 2. To develop in vivo strategies for effective adenoviral vector transduction of oral squamous carcinomas. 3. To determine the effectiveness of transient expression of wild-type p53, p16, p21 (CIP/WAF1), and pRB105 independently and in combination in the growth inhibition and induction of apoptosis in oral squamous carcinomas. 4. To determine whether regulation of transcription factors E2F-1 and DP-1, and the induced gene, p21 (CIP/WAF1), which are downstream of p53, can potentiate the growth inhibition and induction of apoptosis in oral squamous carcinoma cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29DE011689-02
Application #
2430131
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Project Start
1996-08-01
Project End
2001-05-31
Budget Start
1997-06-01
Budget End
1998-05-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Gonzalez, Hernan E; Gujrati, Manu; Frederick, Mitchell et al. (2003) Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:754-9
Nakashima, T; Sun, S Y; Lotan, R et al. (2001) All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma. Laryngoscope 111:1459-64
Clayman, G L (2000) The current status of gene therapy. Semin Oncol 27:39-43
Nakashima, T; Clayman, G L (2000) Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 126:957-61
Nakashima, T; Pak, S C; Silverman, G A et al. (2000) Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cells. Biochim Biophys Acta 1492:441-6
Henderson, Y C; Clayman, G L (2000) An effective method for removing ribosomal RNA during mRNA purification. Methods Cell Sci 22:253-5
Henderson, Y C; Breau, R L; Liu, T J et al. (2000) Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus. Head Neck 22:347-54
Nakashima, T; Hudson, J M; Clayman, G L (2000) Antisense inhibition of vascular endothelial growth factor in human head and neck squamous cell carcinoma. Head Neck 22:483-8
Hong, F D; Clayman, G L (2000) Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. Cancer Res 60:6551-6
Frederick, M J; Henderson, Y; Xu, X et al. (2000) In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol 156:1937-50

Showing the most recent 10 out of 17 publications